<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35563735</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2073-4409</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>22</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cells</Title>
          <ISOAbbreviation>Cells</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Astrocytes Derived from Familial and Sporadic Alzheimer's Disease iPSCs Show Altered Calcium Signaling and Respond Differently to Misfolded Protein Tau.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">1429</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/cells11091429</ELocationID>
        <Abstract>
          <AbstractText>Astrocytes regulate important functions in the brain, and their dysregulation has been linked to the etiology of neurodegenerative diseases, such as Alzheimer's disease (AD). The role of astroglia in human AD remains enigmatic, owing to the limitations of animal models, which, while recreating some pathological aspects of the disease, do not fully mirror its course. In addition, the recognition of major structural and functional differences between human and mouse astrocytes has also prompted research into human glial cells. In the current study, astrocytes were generated using human iPSCs from patients with sporadic Alzheimer's disease (sAD), familial Alzheimer's disease (fAD) and non-demented controls (NDC). All clones gained astrocyte-specific morphological and proteomic characteristics upon in vitro differentiation, without considerable inter-clonal variances. In comparison to NDC, AD astrocytes displayed aberrant calcium dynamics in response to glutamate. When exposed to monomeric and aggregated tau, AD astrocytes demonstrated hypertrophy and elevated GFAP expression, differential expression of select signaling and receptor proteins, and the enhanced production of metalloproteinases (MMPs). Moreover, astrocytic secretomes were able to degrade tau in both monomeric and pathologically aggregated forms, which was mediated by MMP-2 and -9. The capacity to neutralize tau varied considerably between clones, with fAD astrocytes having the lowest degradability relative to sAD and healthy astrocytes. Importantly, when compared to aggregated tau alone, astrocytic secretome pretreatment of tau differentially reduced its detrimental effects on neurons. Our results show crucial differences in sporadic and familial AD astrocytes and suggests that these cells may play distinctive roles in the pathogenesis of early and late onset Alzheimer's disease.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Brezovakova</LastName>
            <ForeName>Veronika</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Neuroimmunology, Centre of Excellence for Alzheimer's Disease and Related Disorders, Slovak Academy of Sciences, Dubravska 9, 845 10 Bratislava, Slovakia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sykova</LastName>
            <ForeName>Eva</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">0000-0003-0179-0182</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Neuroimmunology, Centre of Excellence for Alzheimer's Disease and Related Disorders, Slovak Academy of Sciences, Dubravska 9, 845 10 Bratislava, Slovakia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jadhav</LastName>
            <ForeName>Santosh</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Neuroimmunology, Centre of Excellence for Alzheimer's Disease and Related Disorders, Slovak Academy of Sciences, Dubravska 9, 845 10 Bratislava, Slovakia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cells</MedlineTA>
        <NlmUniqueID>101600052</NlmUniqueID>
        <ISSNLinking>2073-4409</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>146-14-5</RegistryNumber>
          <NameOfSubstance UI="D005182">Flavin-Adenine Dinucleotide</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001253" MajorTopicYN="Y">Astrocytes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020013" MajorTopicYN="N">Calcium Signaling</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005182" MajorTopicYN="N">Flavin-Adenine Dinucleotide</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Alzheimer’s disease</Keyword>
        <Keyword MajorTopicYN="N">astrocytes</Keyword>
        <Keyword MajorTopicYN="N">iPSCs</Keyword>
        <Keyword MajorTopicYN="N">matrix metalloproteinases</Keyword>
        <Keyword MajorTopicYN="N">tau</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>1</Hour>
          <Minute>8</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35563735</ArticleId>
        <ArticleId IdType="pmc">PMC9101114</ArticleId>
        <ArticleId IdType="doi">10.3390/cells11091429</ArticleId>
        <ArticleId IdType="pii">cells11091429</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Rabinovici G.D. Late-onset Alzheimer Disease. Continuum. 2019;25:14–33. doi: 10.1212/CON.0000000000000700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/CON.0000000000000700</ArticleId>
            <ArticleId IdType="pmc">PMC6548536</ArticleId>
            <ArticleId IdType="pubmed">30707185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jansen I.E., Savage J.E., Watanabe K., Bryois J., Williams D.M., Steinberg S., Sealock J., Karlsson I.K., Hägg S., Athanasiu L., et al.  Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat. Genet. 2019;51:404–413. doi: 10.1038/s41588-018-0311-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41588-018-0311-9</ArticleId>
            <ArticleId IdType="pmc">PMC6836675</ArticleId>
            <ArticleId IdType="pubmed">30617256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ridge P.G., Hoyt K.B., Boehme K., Mukherjee S., Crane P.K., Haines J.L., Mayeux R., Farrer L.A., Pericak-Vance M.A., Schellenberg G.D., et al.  Assessment of the genetic variance of late-onset Alzheimer’s disease. Neurobiol. Aging. 2016;41:e13–e200. doi: 10.1016/j.neurobiolaging.2016.02.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.02.024</ArticleId>
            <ArticleId IdType="pmc">PMC4948179</ArticleId>
            <ArticleId IdType="pubmed">27036079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>González-Reyes R.E., Nava-Mesa M.O., Vargas-Sánchez K., Ariza-Salamanca D., Mora-Muñoz L. Involvement of Astrocytes in Alzheimer’s Disease from a Neuroinflammatory and Oxidative Stress Perspective. Front. Mol. Neurosci. 2017;10:427. doi: 10.3389/fnmol.2017.00427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnmol.2017.00427</ArticleId>
            <ArticleId IdType="pmc">PMC5742194</ArticleId>
            <ArticleId IdType="pubmed">29311817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verkhratsky A., Zorec R., Rodríguez J.J., Parpura V. Astroglia dynamics in ageing and Alzheimer’s disease. Curr. Opin. Pharmacol. 2016;26:74–79. doi: 10.1016/j.coph.2015.09.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.coph.2015.09.011</ArticleId>
            <ArticleId IdType="pubmed">26515274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Syková E., Nicholson C. Diffusion in brain extracellular space. Physiol. Rev. 2008;88:1277–1340. doi: 10.1152/physrev.00027.2007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.00027.2007</ArticleId>
            <ArticleId IdType="pmc">PMC2785730</ArticleId>
            <ArticleId IdType="pubmed">18923183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allen B., Ingram E., Takao M., Smith M.J., Jakes R., Virdee K., Yoshida H., Holzer M., Craxton M., Emson P.C., et al.  Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. Off. J. Soc. Neurosci. 2002;22:9340–9351. doi: 10.1523/JNEUROSCI.22-21-09340.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.22-21-09340.2002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cabezas R., Avila M., Gonzalez J., El-Bachá R.S., Báez E., García-Segura L.M., Jurado Coronel J.C., Capani F., Cardona-Gomez G.P., Barreto G.E. Astrocytic modulation of blood brain barrier: Perspectives on Parkinson’s disease. Front. Cell. Neurosci. 2014;8:211. doi: 10.3389/fncel.2014.00211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2014.00211</ArticleId>
            <ArticleId IdType="pmc">PMC4120694</ArticleId>
            <ArticleId IdType="pubmed">25136294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palombo F., Tamagnini F., Jeynes J.C.G., Mattana S., Swift I., Nallala J., Hancock J., Brown J.T., Randall A.D., Stone N. Detection of Aβ plaque-associated astrogliosis in Alzheimer’s disease brain by spectroscopic imaging and immunohistochemistry. Analyst. 2018;143:850–857. doi: 10.1039/C7AN01747B.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/C7AN01747B</ArticleId>
            <ArticleId IdType="pmc">PMC5851084</ArticleId>
            <ArticleId IdType="pubmed">29230441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Serrano-Pozo A., Muzikansky A., Gómez-Isla T., Growdon J.H., Betensky R.A., Frosch M.P., Hyman B.T. Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2013;72:462–471. doi: 10.1097/NEN.0b013e3182933788.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/NEN.0b013e3182933788</ArticleId>
            <ArticleId IdType="pmc">PMC3661683</ArticleId>
            <ArticleId IdType="pubmed">23656989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan P., Hu X., Song H., Yin K., Bateman R.J., Cirrito J.R., Xiao Q., Hsu F.F., Turk J.W., Xu J., et al.  Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J. Biol. Chem. 2006;281:24566–24574. doi: 10.1074/jbc.M602440200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M602440200</ArticleId>
            <ArticleId IdType="pubmed">16787929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin K.J., Cirrito J.R., Yan P., Hu X., Xiao Q., Pan X., Bateman R., Song H., Hsu F.F., Turk J., et al.  Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J. Neurosci. Off. J. Soc. Neurosci. 2006;26:10939–10948. doi: 10.1523/JNEUROSCI.2085-06.2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2085-06.2006</ArticleId>
            <ArticleId IdType="pmc">PMC6674654</ArticleId>
            <ArticleId IdType="pubmed">17065436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terni B., Ferrer I. Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer’s Disease-Related Pathology. J. Alzheimer’s Dis. JAD. 2015;46:461–469. doi: 10.3233/JAD-142460.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3233/JAD-142460</ArticleId>
            <ArticleId IdType="pubmed">26402409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohamed N.V., Herrou T., Plouffe V., Piperno N., Leclerc N. Spreading of tau pathology in Alzheimer’s disease by cell-to-cell transmission. Eur. J. Neurosci. 2013;37:1939–1948. doi: 10.1111/ejn.12229.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ejn.12229</ArticleId>
            <ArticleId IdType="pubmed">23773063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maphis N., Xu G.X., Kokiko-Cochran O.N., Jiang S., Cardona A., Ransohoff R.M., Lamb B.T., Bhaskar K. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain A J. Neurol. 2015;138:1738–1755. doi: 10.1093/brain/awv081.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awv081</ArticleId>
            <ArticleId IdType="pmc">PMC4542622</ArticleId>
            <ArticleId IdType="pubmed">25833819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spanic E., Horvat L.L., Hof P.R., Simic G. Role of Microglial Cells in Alzheimer’s Disease Tau Propagation. Front. Aging Neurosci. 2019;11:271. doi: 10.3389/fnagi.2019.00271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnagi.2019.00271</ArticleId>
            <ArticleId IdType="pmc">PMC6787141</ArticleId>
            <ArticleId IdType="pubmed">31636558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martini-Stoica H., Cole A.L., Swartzlander D.B., Chen F., Wan Y.W., Bajaj L., Bader D.A., Lee V.M.Y., Trojanowski J.Q., Liu Z., et al.  TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading. J. Exp. Med. 2018;215:2355–2377. doi: 10.1084/jem.20172158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20172158</ArticleId>
            <ArticleId IdType="pmc">PMC6122971</ArticleId>
            <ArticleId IdType="pubmed">30108137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perea J.R., Llorens-Martín M., Ávila J., Bolós M. The Role of Microglia in the Spread of Tau: Relevance for Tauopathies. Front. Cell. Neurosci. 2018;12:172. doi: 10.3389/fncel.2018.00172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2018.00172</ArticleId>
            <ArticleId IdType="pmc">PMC6048186</ArticleId>
            <ArticleId IdType="pubmed">30042659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kovacs G.G., Ferrer I., Grinberg L.T., Alafuzoff I., Attems J., Budka H., Cairns N.J., Crary J.F., Duyckaerts C., Ghetti B., et al.  Aging-related tau astrogliopathy (ARTAG): Harmonized evaluation strategy. Acta Neuropathol. 2016;131:87–102. doi: 10.1007/s00401-015-1509-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-015-1509-x</ArticleId>
            <ArticleId IdType="pmc">PMC4879001</ArticleId>
            <ArticleId IdType="pubmed">26659578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kovacs G.G., Lee V.M., Trojanowski J.Q. Protein astrogliopathies in human neurodegenerative diseases and aging. Brain Pathol. 2017;27:675–690. doi: 10.1111/bpa.12536.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bpa.12536</ArticleId>
            <ArticleId IdType="pmc">PMC5578412</ArticleId>
            <ArticleId IdType="pubmed">28805003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fleeman R.M., Proctor E.A. Astrocytic Propagation of Tau in the Context of Alzheimer’s Disease. Front. Cell. Neurosci. 2021;15:645233. doi: 10.3389/fncel.2021.645233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2021.645233</ArticleId>
            <ArticleId IdType="pmc">PMC8010320</ArticleId>
            <ArticleId IdType="pubmed">33815065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wisniewski T., Sigurdsson E.M. Murine models of Alzheimer’s disease and their use in developing immunotherapies. Biochim. Biophys. Acta. 2010;1802:847–859. doi: 10.1016/j.bbadis.2010.05.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2010.05.004</ArticleId>
            <ArticleId IdType="pmc">PMC2930136</ArticleId>
            <ArticleId IdType="pubmed">20471477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schindowski K., Bretteville A., Leroy K., Bégard S., Brion J.P., Hamdane M., Buée L. Alzheimer’s disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am. J. Pathol. 2006;169:599–616. doi: 10.2353/ajpath.2006.060002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2353/ajpath.2006.060002</ArticleId>
            <ArticleId IdType="pmc">PMC1698785</ArticleId>
            <ArticleId IdType="pubmed">16877359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zilka N., Filipcik P., Koson P., Fialova L., Skrabana R., Zilkova M., Rolkova G., Kontsekova E., Novak M. Truncated tau from sporadic Alzheimer’s disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett. 2006;580:3582–3588. doi: 10.1016/j.febslet.2006.05.029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.febslet.2006.05.029</ArticleId>
            <ArticleId IdType="pubmed">16753151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heneka M.T., Carson M.J., El Khoury J., Landreth G.E., Brosseron F., Feinstein D.L., Jacobs A.H., Wyss-Coray T., Vitorica J., Ransohoff R.M., et al.  Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14:388–405. doi: 10.1016/S1474-4422(15)70016-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(15)70016-5</ArticleId>
            <ArticleId IdType="pmc">PMC5909703</ArticleId>
            <ArticleId IdType="pubmed">25792098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verkhratsky A. Astroglial Calcium Signaling in Aging and Alzheimer’s Disease. Cold Spring Harb. Perspect. Biol. 2019;11:a035188. doi: 10.1101/cshperspect.a035188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/cshperspect.a035188</ArticleId>
            <ArticleId IdType="pmc">PMC6601464</ArticleId>
            <ArticleId IdType="pubmed">31110130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du Y., Deng W., Wang Z., Ning M., Zhang W., Zhou Y., Lo E.H., Xing C. Differential subnetwork of chemokines/cytokines in human, mouse, and rat brain cells after oxygen-glucose deprivation. J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab. 2017;37:1425–1434. doi: 10.1177/0271678X16656199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0271678X16656199</ArticleId>
            <ArticleId IdType="pmc">PMC5453462</ArticleId>
            <ArticleId IdType="pubmed">27328691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eidsvaag V.A., Enger R., Hansson H.A., Eide P.K., Nagelhus E.A. Human and mouse cortical astrocytes differ in aquaporin-4 polarization toward microvessels. Glia. 2017;65:964–973. doi: 10.1002/glia.23138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.23138</ArticleId>
            <ArticleId IdType="pmc">PMC5413834</ArticleId>
            <ArticleId IdType="pubmed">28317216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Penney J., Ralvenius W.T., Tsai L.H. Modeling Alzheimer’s disease with iPSC-derived brain cells. Mol. Psychiatry. 2020;25:148–167. doi: 10.1038/s41380-019-0468-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41380-019-0468-3</ArticleId>
            <ArticleId IdType="pmc">PMC6906186</ArticleId>
            <ArticleId IdType="pubmed">31391546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foveau B., Correia A.S., Hébert S.S., Rainone S., Potvin O., Kergoat M.J., Belleville S., Duchesne S., LeBlanc A.C. Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer’s Disease. J. Alzheimer’s Dis. JAD. 2019;67:893–910. doi: 10.3233/JAD-180833.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3233/JAD-180833</ArticleId>
            <ArticleId IdType="pubmed">30689579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birnbaum J.H., Wanner D., Gietl A.F., Saake A., Kündig T.M., Hock C., Nitsch R.M., Tackenberg C. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer’s disease patients. Stem Cell Res. 2018;27:121–130. doi: 10.1016/j.scr.2018.01.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.scr.2018.01.019</ArticleId>
            <ArticleId IdType="pubmed">29414602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duan L., Bhattacharyya B.J., Belmadani A., Pan L., Miller R.J., Kessler J.A. Stem cell derived basal forebrain cholinergic neurons from Alzheimer’s disease patients are more susceptible to cell death. Mol. Neurodegener. 2014;9:3. doi: 10.1186/1750-1326-9-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1750-1326-9-3</ArticleId>
            <ArticleId IdType="pmc">PMC3896712</ArticleId>
            <ArticleId IdType="pubmed">24401693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Israel M.A., Yuan S.H., Bardy C., Reyna S.M., Mu Y., Herrera C., Hefferan M.P., Van Gorp S., Nazor K.L., Boscolo F.S., et al.  Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells. Nature. 2012;482:216–220. doi: 10.1038/nature10821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10821</ArticleId>
            <ArticleId IdType="pmc">PMC3338985</ArticleId>
            <ArticleId IdType="pubmed">22278060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin Y.T., Seo J., Gao F., Feldman H.M., Wen H.L., Penney J., Cam H.P., Gjoneska E., Raja W.K., Cheng J., et al.  APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types. Neuron. 2018;98:1141–1154.e7. doi: 10.1016/j.neuron.2018.05.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2018.05.008</ArticleId>
            <ArticleId IdType="pmc">PMC6023751</ArticleId>
            <ArticleId IdType="pubmed">29861287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ochalek A., Mihalik B., Avci H.X., Chandrasekaran A., Téglási A., Bock I., Giudice M.L., Táncos Z., Molnár K., László L., et al.  Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation. Alzheimer’s Res. Ther. 2017;9:90. doi: 10.1186/s13195-017-0317-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13195-017-0317-z</ArticleId>
            <ArticleId IdType="pmc">PMC5709977</ArticleId>
            <ArticleId IdType="pubmed">29191219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oksanen M., Petersen A.J., Naumenko N., Puttonen K., Lehtonen Š., Gubert Olivé M., Shakirzyanova A., Leskelä S., Sarajärvi T., Viitanen M., et al.  PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer’s Disease. Stem Cell Rep. 2017;9:1885–1897. doi: 10.1016/j.stemcr.2017.10.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stemcr.2017.10.016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nemes C., Varga E., Táncos Z., Bock I., Francz B., Kobolák J., Dinnyés A. Establishment of PSEN1 mutant induced pluripotent stem cell (iPSC) line from an Alzheimer’s disease (AD) female patient. Stem Cell Res. 2016;17:69–71. doi: 10.1016/j.scr.2016.05.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.scr.2016.05.019</ArticleId>
            <ArticleId IdType="pubmed">27558604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ochalek A., Nemes C., Varga E., Táncos Z., Kobolák J., Dinnyés A. Establishment of induced pluripotent stem cell (iPSC) line from a 57-year old patient with sporadic Alzheimer’s disease. Stem Cell Res. 2016;17:72–74. doi: 10.1016/j.scr.2016.05.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.scr.2016.05.020</ArticleId>
            <ArticleId IdType="pubmed">27558605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palm T., Bolognin S., Meiser J., Nickels S., Träger C., Meilenbrock R.-L., Brockhaus J., Schreitmüller M., Missler M., Schwamborn J.C. Rapid and robust generation of long-term self-renewing human neural stem cells with the ability to generate mature astroglia. Sci. Rep. 2015;5:16321. doi: 10.1038/srep16321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep16321</ArticleId>
            <ArticleId IdType="pmc">PMC4635383</ArticleId>
            <ArticleId IdType="pubmed">26541394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gosselin R.D., Meylan P., Decosterd I. Extracellular microvesicles from astrocytes contain functional glutamate transporters: Regulation by protein kinase C and cell activation. Front. Cell. Neurosci. 2013;7:251. doi: 10.3389/fncel.2013.00251.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2013.00251</ArticleId>
            <ArticleId IdType="pmc">PMC3857901</ArticleId>
            <ArticleId IdType="pubmed">24368897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radstake F.D.W., Raaijmakers E.A.L., Luttge R., Zinger S., Frimat J.P. CALIMA: The semi-automated open-source calcium imaging analyzer. Comput. Methods Programs Biomed. 2019;179:104991. doi: 10.1016/j.cmpb.2019.104991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmpb.2019.104991</ArticleId>
            <ArticleId IdType="pmc">PMC6718774</ArticleId>
            <ArticleId IdType="pubmed">31443860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moein M., Grzyb K., Gonçalves Martins T., Komoto S., Peri F., Crawford A.D., Fouquier d’Herouel A., Skupin A. CaSiAn: A Calcium Signaling Analyzer tool. Bioinformatics. 2018;34:3052–3054. doi: 10.1093/bioinformatics/bty281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bioinformatics/bty281</ArticleId>
            <ArticleId IdType="pmc">PMC6129310</ArticleId>
            <ArticleId IdType="pubmed">29668830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Csokova N., Skrabana R., Liebig H.-D., Mederlyova A., Kontsek P., Novak M. Rapid purification of truncated tau proteins: Model approach to purification of functionally active fragments of disordered proteins, implication for neurodegenerative diseases. Protein Expr. Purif. 2004;35:366–372. doi: 10.1016/j.pep.2004.01.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pep.2004.01.012</ArticleId>
            <ArticleId IdType="pubmed">15135415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Majerova P., Zilkova M., Kazmerova Z., Kovac A., Paholikova K., Kovacech B., Zilka N., Novak M. Microglia display modest phagocytic capacity for extracellular tau oligomers. J. Neuroinflamm. 2014;11:161. doi: 10.1186/s12974-014-0161-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12974-014-0161-z</ArticleId>
            <ArticleId IdType="pmc">PMC4172893</ArticleId>
            <ArticleId IdType="pubmed">25217135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sasaki K., Shimura H., Itaya M., Tanaka R., Mori H., Mizuno Y., Kosik K.S., Tanaka S., Hattori N. Excitatory amino acid transporter 2 associates with phosphorylated tau and is localized in neurofibrillary tangles of tauopathic brains. FEBS Lett. 2009;583:2194–2200. doi: 10.1016/j.febslet.2009.06.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.febslet.2009.06.015</ArticleId>
            <ArticleId IdType="pubmed">19527721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foster J.B., Lashley R., Zhao F., Wang X., Kung N., Askwith C.C., Lin L., Shultis M.W., Hodgetts K.J., Lin C.G. Enhancement of tripartite synapses as a potential therapeutic strategy for Alzheimer’s disease: A preclinical study in rTg4510 mice. Alzheimer’s Res. Ther. 2019;11:75. doi: 10.1186/s13195-019-0530-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13195-019-0530-z</ArticleId>
            <ArticleId IdType="pmc">PMC6706914</ArticleId>
            <ArticleId IdType="pubmed">31439023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pei J.J., Braak H., An W.L., Winblad B., Cowburn R.F., Iqbal K., Grundke-Iqbal I. Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer’s disease. Brain Res. Mol. Brain Res. 2002;109:45–55. doi: 10.1016/S0169-328X(02)00488-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0169-328X(02)00488-6</ArticleId>
            <ArticleId IdType="pubmed">12531514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Webster B., Hansen L., Adame A., Crews L., Torrance M., Thal L., Masliah E. Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease. J. Neuropathol. Exp. Neurol. 2006;65:142–151. doi: 10.1097/01.jnen.0000199599.63204.6f.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.jnen.0000199599.63204.6f</ArticleId>
            <ArticleId IdType="pubmed">16462205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perriot S., Mathias A., Perriard G., Canales M., Jonkmans N., Merienne N., Meunier C., El Kassar L., Perrier A.L., Laplaud D.A., et al.  Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines. Stem Cell Rep. 2018;11:1199–1210. doi: 10.1016/j.stemcr.2018.09.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stemcr.2018.09.015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shigetomi E., Patel S., Khakh B.S. Probing the Complexities of Astrocyte Calcium Signaling. Trends Cell Biol. 2016;26:300–312. doi: 10.1016/j.tcb.2016.01.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tcb.2016.01.003</ArticleId>
            <ArticleId IdType="pmc">PMC4946798</ArticleId>
            <ArticleId IdType="pubmed">26896246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cortes L., Malva J., Rego A.C., Pereira C.F. Calcium Signaling in Aging and Neurodegenerative Diseases 2019. Int. J. Mol. Sci. 2020;21:1125.  doi: 10.3390/ijms21031125.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21031125</ArticleId>
            <ArticleId IdType="pmc">PMC7037616</ArticleId>
            <ArticleId IdType="pubmed">32046230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brawek B., Garaschuk O. Network-wide dysregulation of calcium homeostasis in Alzheimer’s disease. Cell Tissue Res. 2014;357:427–438. doi: 10.1007/s00441-014-1798-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00441-014-1798-8</ArticleId>
            <ArticleId IdType="pubmed">24553999</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Irwin D.J., Cohen T.J., Grossman M., Arnold S.E., Xie S.X., Lee V.M., Trojanowski J.Q. Acetylated tau, a novel pathological signature in Alzheimer’s disease and other tauopathies. Pt 3Brain A J. Neurol. 2012;135:807–818. doi: 10.1093/brain/aws013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/aws013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richetin K., Steullet P., Pachoud M., Perbet R., Parietti E., Maheswaran M., Eddarkaoui S., Bégard S., Pythoud C., Rey M., et al.  Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer’s disease. Nat. Neurosci. 2020;23:1567–1579. doi: 10.1038/s41593-020-00728-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41593-020-00728-x</ArticleId>
            <ArticleId IdType="pubmed">33169029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Söllvander S., Nikitidou E., Brolin R., Söderberg L., Sehlin D., Lannfelt L., Erlandsson A. Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons. Mol. Neurodegener. 2016;11:38. doi: 10.1186/s13024-016-0098-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13024-016-0098-z</ArticleId>
            <ArticleId IdType="pmc">PMC4865996</ArticleId>
            <ArticleId IdType="pubmed">27176225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Figiel M., Maucher T., Rozyczka J., Bayatti N., Engele J. Regulation of glial glutamate transporter expression by growth factors. Exp. Neurol. 2003;183:124–135. doi: 10.1016/S0014-4886(03)00134-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0014-4886(03)00134-1</ArticleId>
            <ArticleId IdType="pubmed">12957496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodriguez-Kern A., Gegelashvili M., Schousboe A., Zhang J., Sung L., Gegelashvili G. Beta-amyloid and brain-derived neurotrophic factor, BDNF, up-regulate the expression of glutamate transporter GLT-1/EAAT2 via different signaling pathways utilizing transcription factor NF-kappaB. Neurochem. Int. 2003;43:363–370. doi: 10.1016/S0197-0186(03)00023-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0197-0186(03)00023-8</ArticleId>
            <ArticleId IdType="pubmed">12742080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Husain S., Jafri F., Crosson C.E. Acute effects of PGF2alpha on MMP-2 secretion from human ciliary muscle cells: A PKC- and ERK-dependent process. Investig. Ophthalmol. Vis. Sci. 2005;46:1706–1713. doi: 10.1167/iovs.04-0993.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.04-0993</ArticleId>
            <ArticleId IdType="pubmed">15851572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arai K., Lee S.R., Lo E.H. Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes. Glia. 2003;43:254–264. doi: 10.1002/glia.10255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.10255</ArticleId>
            <ArticleId IdType="pubmed">12898704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruhul Amin A.R., Senga T., Oo M.L., Thant A.A., Hamaguchi M. Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: A role for the dual signalling pathways, Akt and Erk. Genes Cells Devoted Mol. Cell. Mech. 2003;8:515–523. doi: 10.1046/j.1365-2443.2003.00652.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2443.2003.00652.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X.X., Tan M.S., Yu J.T., Tan L. Matrix metalloproteinases and their multiple roles in Alzheimer’s disease. Biomed. Res. Int. 2014;2014:908636. doi: 10.1155/2014/908636.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/908636</ArticleId>
            <ArticleId IdType="pmc">PMC4094696</ArticleId>
            <ArticleId IdType="pubmed">25050378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernandez-Guillamon M., Mawhirt S., Blais S., Montaner J., Neubert T.A., Rostagno A., Ghiso J. Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9. J. Biol. Chem. 2015;290:15078–15091. doi: 10.1074/jbc.M114.610931.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M114.610931</ArticleId>
            <ArticleId IdType="pmc">PMC4463451</ArticleId>
            <ArticleId IdType="pubmed">25897080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miners J.S., Baig S., Palmer J., Palmer L.E., Kehoe P.G., Love S. Abeta-degrading enzymes in Alzheimer’s disease. Brain Pathol. 2008;18:240–252. doi: 10.1111/j.1750-3639.2008.00132.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1750-3639.2008.00132.x</ArticleId>
            <ArticleId IdType="pmc">PMC8095507</ArticleId>
            <ArticleId IdType="pubmed">18363935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu Z.H., Yang R., Fu X., Wang Y.Q., Wu G.C. Astrocyte-conditioned medium protecting hippocampal neurons in primary cultures against corticosterone-induced damages via PI3-K/Akt signal pathway. Brain Res. 2006;1114:1–10. doi: 10.1016/j.brainres.2006.07.070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainres.2006.07.070</ArticleId>
            <ArticleId IdType="pubmed">16930567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baez M.V., Cercato M.C., Jerusalinsky D.A. NMDA Receptor Subunits Change after Synaptic Plasticity Induction and Learning and Memory Acquisition. Neural Plast. 2018;2018:5093048. doi: 10.1155/2018/5093048.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2018/5093048</ArticleId>
            <ArticleId IdType="pmc">PMC5863338</ArticleId>
            <ArticleId IdType="pubmed">29706992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goedert M., Jakes R., Crowther R.A. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett. 1999;450:306–311. doi: 10.1016/S0014-5793(99)00508-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0014-5793(99)00508-6</ArticleId>
            <ArticleId IdType="pubmed">10359094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nacharaju P., Lewis J., Easson C., Yen S., Hackett J., Hutton M., Yen S.H. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. FEBS Lett. 1999;447:195–199. doi: 10.1016/S0014-5793(99)00294-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0014-5793(99)00294-X</ArticleId>
            <ArticleId IdType="pubmed">10214944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pérez M., Valpuesta J.M., Medina M., Montejo de Garcini E., Avila J. Polymerization of tau into filaments in the presence of heparin: The minimal sequence required for tau-tau interaction. J. Neurochem. 1996;67:1183–1190. doi: 10.1046/j.1471-4159.1996.67031183.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1471-4159.1996.67031183.x</ArticleId>
            <ArticleId IdType="pubmed">8752125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang P., Ye Y. Filamentous recombinant human Tau activates primary astrocytes via an integrin receptor complex. Nat. Commun. 2021;12:95. doi: 10.1038/s41467-020-20322-w.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-020-20322-w</ArticleId>
            <ArticleId IdType="pmc">PMC7782792</ArticleId>
            <ArticleId IdType="pubmed">33398028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Filipcik P., Zilka N., Bugos O., Kucerak J., Koson P., Novak P., Novak M. First transgenic rat model developing progressive cortical neurofibrillary tangles. Neurobiol. Aging. 2012;33:1448–1456. doi: 10.1016/j.neurobiolaging.2010.10.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neurobiolaging.2010.10.015</ArticleId>
            <ArticleId IdType="pubmed">21196063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang W., Falcon B., Murzin A.G., Fan J., Crowther R.A., Goedert M., Scheres S.H. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases. eLife. 2019;8:e43584. doi: 10.7554/eLife.43584.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.43584</ArticleId>
            <ArticleId IdType="pmc">PMC6375701</ArticleId>
            <ArticleId IdType="pubmed">30720432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kondo T., Asai M., Tsukita K., Kutoku Y., Ohsawa Y., Sunada Y., Imamura K., Egawa N., Yahata N., Okita K., et al.  Modeling Alzheimer’s disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. Cell Stem Cell. 2013;12:487–496. doi: 10.1016/j.stem.2013.01.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stem.2013.01.009</ArticleId>
            <ArticleId IdType="pubmed">23434393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Armijo E., Gonzalez C., Shahnawaz M., Flores A., Davis B., Soto C. Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer’s disease (PSEN1-A246E) induced pluripotent stem cells. Neurosci. Lett. 2017;639:74–81. doi: 10.1016/j.neulet.2016.12.060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neulet.2016.12.060</ArticleId>
            <ArticleId IdType="pubmed">28034781</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
